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Health programming for men who have sex with men (MSM) in South Africa has been ignored or absent until fairly recently, 
despite this population being at high risk for HIV acquisition and transmission. Anova Health Institute, with support from 
the US President's Emergency Plan for AIDS Relief (PEPFAR)/United States Agency for International Development (USAID) 
and in collaboration with the South African National Department of Health, launched the first state sector MSM-targeted 
sexual health clinic in 2010. The clinic has been successful in attracting and retaining MSM in care, and lessons learned are 
described in this article. Components contributing to the creation of MSM-appropriate healthcare services are discussed.
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Until fairly recently, the healthcare needs of 
men who have sex with men (MSM) have 
been under-researched and under-resourced in 
South Africa (SA).[1] This has occurred despite 
emerging local evidence confirming high rates 
of HIV among this key population. Notwithstanding inclusion in 
the country’s previous National Strategic Plan for HIV and AIDS, 
STIs and TB (2007 - 2011), services for MSM were not scaled up 
nationally, although impressive strides have been made in some 
provinces such as the Western Cape and Gauteng. Evidence from 
modelling studies shows that in settings where concentrated 
HIV epidemics exist among key populations in countries with 
generalised heterosexual epidemics, failure to provide targeted 
and tailored HIV prevention and treatment programmes to 
key populations negatively affects HIV rates among the general 
population.[2] 
MSM in SA comprise of a diverse group of men who share 
only one behavioural commonality: they have sex with other 
men.[3] Many MSM in SA do not identify with gay culture, 
which may be viewed as a Eurocentric cultural construct 
often considered foreign and ‘un-African’.[4] The behaviour of 
MSM has, however, occurred across all cultures and all times, 
including in SA, and is therefore well described in African oral 
histories. Colonial oppressors were largely responsible for the 
criminalisation of sodomy on the continent.[5] Homosexual 
activity in SA therefore often remains clandestine, with MSM 
identifying as heterosexual and dismissive of Westernised gay 
culture.[3] This has implications for health messaging as non-
gay-identifying MSM are not targeted in either mainstream 
heterosexual or gay media platforms and remain invisible in 
healthcare settings.
For multi-factorial reasons, MSM are at particular risk for 
HIV acquisition and transmission.[6] Biologically, unprotected 
receptive anal sexual intercourse is about 16 times more likely 
to transmit HIV than unprotected vaginal sexual intercourse. [7] 
This is due to the friable nature of the rectal mucosa, which 
does not contain mucous-producing cells like the thicker, self-
lubricating lining of the vagina. 
The vulnerability of MSM is further increased by structural 
factors such as a lack of funding for MSM-appropriate 
services, lack of specific skills training of health providers, 
and institutionalised stigma within the public healthcare 
sector. MSM patients generally avoid being identified as 
MSM, culminating in their elevated risk of HIV acquisition, 
transmission being overlooked, and a lack of counselling about 
the risks associated with unprotected anal sex.[8] 
Organisations such as the Anova Health Institute, through 
it’s innovative Health4Men project, and the Desmond Tutu 
HIV Foundation have been active in addressing these concerns 
in SA. In 2009 the Anova Health Institute, with support from 
the US President's Emergency Plan for AIDS Relief (PEPFAR)/
United States Agency for International Development (USAID), 
launched the first state sector clinic dedicated to MSM in the 
country. A further 6 sites have subsequently become operational 
across multiple provinces. Invaluable lessons have been learned 
through this process, which will undoubtedly serve as a template 
for the ongoing expansion of such services.[4,9-11]
MSM experience mainstream state sector healthcare 
services as unfriendly and prejudiced, which creates a 
barrier to accessing such services.[12] Many local healthcare 
centres have become friendly to women at the exclusion of 










they attend for antenatal care, childhood 
vaccinations, completion of children’s road-
to-health growth charts and other services. 
Clinics respond by improving their female-
specific skills and services. It is not unusual 
to find most of the educational materials 
in HIV clinics focusing on issues such as 
breastfeeding and female contraception, 
thereby alienating HIV-positive men. Other 
barriers to MSM healthcare access include 
fears about confidentiality related to their 
HIV status and sexual behaviour. The 
local catchment area of primary healthcare 
services is also often problematic; MSM who 
experience community-based stigma are 
unlikely to attend a clinic where they are 
known to other patients or staff members.
For a health provision site to be considered 
MSM-appropriate, a number of criteria need 
to be met. Firstly, most MSM require more 
than a friendly service (often incorrectly 
referred to as an MSM-sensitised service); they 
expect competence regarding their specific 
sexual healthcare needs. Services therefore 
need to be both sensitive and competent if 
they are to attract and retain MSM in care.[4]
The Ivan Toms Centre for Men’s Health 
(ITCMH), a clinic of the Anova Health 
Institute in partnership with the Western Cape 
Department of Health (DoH) and funded by 
PEPFAR through USAID, was inaugurated 
in February 2010 in Cape Town. It has since 
provided care to over 3 800 MSM. There are 
a few features which have contributed to the 
success of this clinic. There is buy-in and 
commitment by the provincial and National 
DoH.[13] The service is marketed as a sexual 
health clinic for men. It is neither an HIV 
nor an antiretroviral therapy (ART) clinic, 
which means that patients in the waiting 
room cannot be identified as HIV-positive. 
Approximately half of the clients in the 
cohort are HIV-positive and half of those are 
receiving ART. Other MSM attend for HIV and 
sexually transmitted infection (STI) screening, 
syndromic STI management, counselling 
and other mental healthcare services, harm-
reduction services for MSM who use drugs, or 
for research and information purposes. This 
model assists in providing an enabling space 
that promotes feelings of anonymity regarding 
the reason for attendance, and allays fears of 
being identified as gay or HIV-infected when 
attending the clinic.
Clinic staff have received extensive 
sensitivity and competency training and are 
accepting of the diversity of MSM. They have 
become accustomed to providing service to 
MSM with either a feminine or masculine 
gender-identity, as well as to transgendered 
individuals. All staff are accustomed to 
referring to clients by their preferred name 
and pronoun (as opposed to their legal name). 
Table 1. Recommended service package for addressing the sexual health of MSM: HIV/AIDS
Primary care prevention (HIV/AIDS) Primary care treatment (HIV/AIDS) Optimal specialised care
• HCT with MSM-appropriate counselling 
yearly or more frequently if possible 
exposures
• Condoms and water-based sexual lubricant
• Female condoms for anal sexual 
intercourse
• Access to early ART if HIV-positive to 
prevent transmission to sexual partners 
('treatment as prevention')
• Accessible PEP according to PEP protocols
• Targeted PrEP when available (local 
guidelines available in a previous issue of 
SAJHIVMED*)
• Counselling for behaviour change
• Reduce numbers of sexual partners
• Increase condom use, especially for the 
highest risk sexual behaviours (e.g. anal 
sex)
• Sero-sorting (choosing sexual partners on 
the basis of HIV status)
• Sero-positioning (choosing to be receptive 
in anal sex if HIV-positive and penetrative 
if HIV-negative)
• Address alcohol, recreational drug and 
tobacco use
• Screen and address mental health issues 
(e.g. depression)
• Screen and treat for STIs yearly or more 
frequently if high risk
• CD4+ count monitoring 6-monthly (point of 
care or laboratory)
• Commence ART when:
• CD4+ ≤350 cells/μl
• WHO stage IV
• Malignancies 
(i.e. according to standard in-country 
guidelines on when to initiate ART)
• Use ART according to local guidelines
• TDF/FTC/EFV fixed-dose combination
• AZT/3TC/Aluvia second-line
• Monitor for side-effects and efficacy according 
to local guidelines
• CD4+ measurement
• VL at 6 and 12 months, then yearly
• FBC, if receiving AZT
• ALT, if receiving NVP
• Creatinine clearance at ART initiation and 
yearly if receiving TDF
• Cholesterol, triglyceride and glucose
• Monitor adherence 
• Self-reported
• Pill counts
• Pharmacy script refills
• Knowledge of ART drugs
• CD4+ and VL monitoring 3 - 6-monthly 
• Consider earlier ART initiation at high 
CD4+ count; patient will benefit directly and 
there is less chance of HIV transmission to 
sexual partners (i.e. less transmission within 
the MSM community) ('ART as prevention')
• Consider early ART initiation for all 
hepatitis B/C and HIV co-infections 
• Expanded ART choice including ABC and 
ritonavir-boosted ATV to improve regimen 
tolerability if side-effects (also consider new 
classes of ART)
• Extended monitoring
• CD4+ and VL 3 - 6-monthly
• Creatine clearance at 1, 3 and 6 months 
and then 6-monthly
• Cholesterol, triglyceride and glucose
• DEXA scan for osteopaenia if receiving 
long-term TDF and other risk factors for 
bone disease
• HLA typing if planning to use abacavir
• Extended adherence monitoring using 
devices such as pill bottles which register 
when they are opened
• Consider PrEP for HIV-negative MSM with 
known high possible exposure rates to HIV
• Discordant couples
• Ongoing high-risk sexual behaviours
• Commercial sex workers
• Drug users
MSM = men who have sex with men; HCT = HIV counselling and testing; ART = antiretroviral therapy; PEP = post-exposure prophylaxis; PrEP = pre-exposure prophylaxis; STI = sexually 
transmitted infection; WHO = World Health Organization; SA = South Africa; TDF = tenofovir; FTC = emtricitabine; 3TC = lamivudine; EFV = efavirenz; NVP = nevirapine; AZT = zidovudine; 
VL = viral load; FBC = full blood count; ALT = alanine transaminase; ABC = abacavir; ATV = atazanavir; HLA = human leukocyte antigen; DEXA = dual energy X-ray absorptiometry.
*  Southern African HIV Clinicians Society Consensus Committee. Southern African guidelines for the safe use of pre-exposure prophylaxis in men who have sex with men who are at risk for HIV 
infection. Southern African Journal of HIV Medicine 2012;13(2):40-55. [http://dx.doi.org/10.7196/SAJHIVMED.832]





Table 2. Recommended service package for addressing the sexual health of MSM: STIs
Disease Primary care prevention (STIs) Primary care treatment (STIs) Optimal specialised care
Gonorrhoea • Regular screening for 
symptoms
• Condoms and water-based 
lubricant
• Risk-reduction counselling as 
for HIV
• Syndromic treatment according to 
SA guidelines
• Partner(s) notification and 
treatment
• Be aware that gonorrhoea can occur 
in the urethra, pharynx or anus of 
MSM
• Consider drug-resistant gonorrhoea 
in cases of treatment failure
• Confirm diagnosis with swab- and 
laboratory-based testing, including NAATs 
where available
• Treat confirmed cases as for primary care
• Consider screening for asymptomatic 
disease at urethral and non-urethral sites
Chlamydia • Regular screening for 
symptoms
• Condoms and water-based 
lubricant
• Risk-reduction counselling as 
for HIV
• Syndromic treatment according to 
SA guidelines
• Partner(s) notification and 
treatment
• Be aware that chlamydial infections 
occur in the urethra, pharynx or 
anus of MSM
• Confirm diagnosis with swab- and 
laboratory-based testing, including NAATs 
where available.
• Consider screening for asymptomatic 
disease (most cases of anal chlamydial 
infection will be asymptomatic)
Syphilis • Regular assessment of risk
• Condoms and water-based 
lubricant
• Risk-reduction counselling 
about transmission
• Confirm syphilis with laboratory-
based RPR and TPHA tests or rapid 
point-of-care test
• Treat at point of care
• Partner(s) notification and 
treatment
• Treat as for primary care
• Consider lumbar puncture for HIV-
positive MSM with positive blood syphilis 





• Regular screening for 
symptoms
• Condoms and water-based 
lubricant
• Treat empirically if STI present 
and prominent inguinal 
lymphadenopathy
• Partner(s) notification and 
treatment




• Transfers easily and not totally 
prevented by condom use, but 
condoms still useful and partly 
effective
• Most easily transferred by 
contact with a visible skin wart, 
but the virus may transfer even 
without visible warts
• Advise to avoid direct contact 
with visible warts
• Cover visible warts with a 
plaster or condom
• Gardasil vaccination will 
prevent some types of warts 
and reduce the risk of HPV-
associated cancers (e.g. anal in 
MSM), but is very expensive
• Treat with topical preparations or 
cryotherapy
• Partner(s) notification and 
treatment
• Refer for surgical opinion if internal 
or extensive disease
• Be aware that penile or anal warts 
can lead to embarrassment and 
pain, resulting in sexual dysfunction
• Can use imiquimod ointment 
preferentially (easier and convenient for 
patient)
• Consider anal pap smear for MSM, 
especially if prior anal warts
• Coagulase laser therapy to anal intra-
epithelial neoplastic lesions (similar to 
cervical intra-epithelial neoplasia in 
women)
• Biopsy any suspicious looking lesions 
and send for histological evaluation 
(MSM have a higher risk of anal cancers 
compared with heterosexual men)
• Vaccinate with Gardasil (ideal to vaccinate 
before onset of sexual debut); might 
prevent warts and decrease risk of cancers; 
may also decrease size of existing HPV 
lesions
Hepatitis A • Counselling about 
transmission (faecal-oral)
• Risk assessment
• Check hepatitis A IgG 
antibodies
• Previous hepatitis A confers 
longstanding immunity
• Vaccinate if susceptible
• Contact trace for 
immunoglobulin and 
vaccination of known contacts
• Supportive treatment of acute 
hepatitis A
• Refer to specialist if clinically unwell
• Monitor liver function tests and 
limit physical activity until settled
• Hepatitis A is potentially serious 
if contracted in adulthood; a small 
percentage of patients develop severe 
liver dysfunction and even failure, and 
consequently require intensive support
• Most cases recover with no permanent 
sequelae as hepatitis A does not have a 
chronic phase
continued ...





Table 2 (continued). Recommended service package for addressing the sexual health of MSM: STIs
Disease Primary care prevention (STIs) Primary care treatment (STIs) Optimal specialised care
Hepatitis B • Counselling about 
transmission
• Risk assessment
• Screen all MSM for hepatitis B 
surface antibodies
• Vaccinate if susceptible
• Contact trace for 
immunoglobulin and 
vaccination of known contacts
• Screen MSM for prior hepatitis 
B infection using hepatitis B 
surface antigen
• Vaccinate all regular hepatitis 
B-negative sexual partners 
of MSM known with chronic 
hepatitis B infections
• Acute hepatitis B requires 
supportive treatment
• Refer if clinically unwell 
(encephalopathic, extreme nausea, 
hypoglycaemia, sepsis, etc.)
• If hepatitis B and HIV co-infected, 
initiate TDF-based ART early 
to prevent disease progression. 
TDF/3TC should then never be 
stopped, even if alternative HIV 
drugs are required in a second-line 
or salvage regimen
• Hepatitis B may be curable with 
interferon therapy, but this is very 
expensive with limited access
• Supportive therapy during acute disease
• Perform liver function tests, hepatitis B 
E-antigen and hepatitis B viral load (these 
parameters assist hepatologists to decide 
who may benefit most from interferon and 
related therapy)
Hepatitis C • Counselling about 
transmission
• Screen HIV-positive MSM who 
use crystal methamphetamine
• Harm-reduction programmes 
for drug users (e.g. needle 
exchange), condoms and water-
based lubricant for anal sex 
• There is no vaccine available; 
only prevention is to avoid 
exposure
• Acute hepatitis C requires 
supportive management
• Refer if clinically unwell 
(encephalopathic, extreme nausea, 
hypoglycaemia, sepsis, etc)
• Antiretroviral medications such 
as TDF/3TC are inactive against 
hepatitis C, but co-infected patients 
should have their HIV treated early 
at high CD4+ counts
• Perform liver function tests, hepatitis C 
viral load and genotyping
• Refer to hepatologist for assessment for 
interferon therapy (lower cure rates than 
for hepatitis B)
• Assess and manage mental health 
in patients taking interferon (causes 
potentially severe depression)
STIs = sexually transmitted infections; MSM = men who have sex with men; NAATs = nucleic acid amplification tests; RPR = rapid plasma reagin; TPHA = treponema pallidum haemaglutination assay; 
LGV = lymphgranuloma venereum; IgG = immunoglobulin G; HPV = human papilloma virus; TDF = tenofovir; 3TC = lamivudine.
Table 3. Examples of interventions for preventing HIV among MSM*
Psychosocial Biomedical
Reducing number of sex partners Increased HCT and early detection of positives
Reducing alcohol and recreational drug use Male and female condoms
Increasing condom use for risky sexual behaviours Condom-compatible sexual lubricant
Increasing the use of condom-compatible lubricant Early ART
Sero-sorting PEP
Sero-positioning STI screening and treatment
Motivational counselling PrEP (refer to SA guidelines)
Couples’ services including targeted counselling Microbicides (undergoing research)
Combating societal homoprejudice and increasing access to 
non-judgemental healthcare services
HIV vaccines (undergoing research)
Screening and management of depression and other mental 
health disorders
Harm-reduction programmes for drug users includes safe injection 
technique, clean injecting equipment (needles), treatment of soft-tissue 
abscesses, IEC materials, education about overdoses and linkage to 
rehabilitation programmes for those who want to stop drug use
Development and dissemination of appropriate healthcare and 
risk-reduction messages that address the specific sexual health 
needs of MSM
Medical male circumcision; does not provide the same risk reduction 
as for heterosexual men but might protect bisexual men and those who 
exclusively adopt the penetrative role in anal sex
MSM = men who have sex with men; HCT = HIV counselling and testing; ART = antiretroviral therapy; PEP = post-exposure prophylaxix; SA = South Africa;  
STI = sexually transmitted infection; PrEP = pre-exposure prophylaxic; IEC = information, education and communication.
*Source: De Swardt and Rebe.[4] 





The scope of practice encompasses holistic 
sexual health, including STI and HIV 
prevention, diagnostic and treatment services, 
as well as in-house access to mental healthcare 
services provided by staff who have specific 
experience in providing such care to MSM. 
Staff have been intensely trained in the specific 
features of sexual health pertaining to MSM. 
Medical staff have an expert understanding 
of how STI presentations, diagnosis and 
management plans differ in MSM, compared 
with heterosexual men. A good example is 
training in physical examination to detect and 
diagnose anal and pharyngeal presentations of 
STIs.
A package of care has been developed for 
the clinic and a clinical manual is available 
for guidance both in print format and 
online (http://www.anovahealth.co.za).[4] It is 
understood that clinics may not be able to 
provide an optimal level of MSM healthcare 
due to resource constraints; therefore, a 
package of minimal and optimal services has 
been developed (see Tables 1 - 3).
Some specific features of the ITCMH that 
have worked well include the provision of 
MSM-sensitive HIV screening. Counsellors 
are trained to ask about male and female 
partners, to identify specific sexual behaviours 
and their risks (e.g. receptive unprotected 
anal intercourse), and to avoid adopting a 
hetero-normative attitude to counselling (such 
as asking an MSM couple which is the man 
and which is the women in a relationship). 
MSM are also encouraged to screen for HIV 
together with their partners.[14] 
Since MSM are at an elevated risk of 
acquiring and transmitting HIV, prevention 
technologies assume particular importance. 
Condoms, although generally available via 
the state, are mainly marketed through 
heterosexually-targeted campaigns that do 
not address the risks of unprotected anal sex. 
Condom-compatible lubricant required for 
comfortable anal sex is largely unavailable. 
Medical male circumcision is likely to fail 
to protect MSM to the same degree as 
heterosexual men, which leaves a deficit of 
effective prevention interventions.[15] Available 
HIV-prevention resources that are evidence-
based – such as condoms, lubricants, post- and 
pre-exposure prophylaxis (PEP and PrEP), 
and early treatment for positive MSM – should 
be prominent at all MSM-targeted sites.
Marketing MSM-appropriate services is 
challenging, especially in areas where MSM 
do not disclose their sexual behaviours and 
remain hidden to the healthcare system. It has 
taken time for MSM groups to develop trust 
in the clinic and the most effective marketing 
has occurred by word of mouth via clients 
who have had a positive health-affirming 
experience at the clinic. Health4Men employs 
peer educators, and key individuals in MSM 
communities from specific geographical areas 
have been recruited as ambassadors for the 
programme. Marketing and information, 
education and communication (IEC) materials 
Fig. 1. The Ukwazana (getting to know each 
other) campaign. An example of HIV risk-
reduction messaging designed to reach MSM 
though township taverns/shebeens where MSM 
congregate.
Fig. 2. An example of HIV risk-reduction messaging designed to reach gay-identified MSM through gay-
targeted publications (the pink press).
MSM resources
South African MSM resources
• Anova Health Institute: http://www.anovahealth.co.za | Tel: +27 (0)11 715 5800
• Health4Men: http://www.health4men.co.za | Tel: +27 (0)21 421 6127 
• The Ivan Toms Centre for Men’s Health | Tel: +27 (0) 21 447 2887
• Health4men Yeoville: email: yeoville@ahovahealth.co.za | Tel: +27 (0)72 654 0816
• Health4Men Connect: http://h4M/mobi  
(MSM-specific information via cellular phone technology)
• Other Health4Men sites or services: email: info@health4men.co.za | Tel: +27 (0)21 421 6127
• Durban Lesbian and Gay Community Centre: email: info@gaycentre.org.za |  
Tel: +27(0)31 301 2145 
• Gay and Lesbian Network (Pietermaritzburg): email: info@gaylesbiankzn.org |  
Tel: +27(0) 33 342 6165
• OUT LGBTI Well Being (Pretoria): email: administrator@out.org.za | Tel: +27(0)12 344 5108
• The Desmond Tutu HIV Centre: http://www.desmondtutuhivcentre.org.za |  
Tel: +27(0)21 650 6966
• Triangle Project (Cape Town): email: info@triangle.org.za | Tel: +27(0)21 686 1475
International website resources for MSM health
• The Body: http://www.thebody.com 
• Gay Men Fighting AIDS: http://www.gmfa.org.za 
• The Global Forum on MSM and HIV (MSMGF): http://www.msmgf.org 
• International Rectal Microbicides Advocates: http://www.rectalmicrobicides.org 





have been developed through testing with 
MSM focus groups to ensure that the language 
is locally understood and contextually correct. 
Health information, referral links and 
interactive questions and answers are also 
available from the Health4Men’s mHealth 
programme ‘Health4men Connect’ (h4m.
mobi) and the programme’s website.
The ITCMH was followed by the launch of 
the Simon Nkoli Centre For Men’s Health in 
Soweto and, more recently, the Khayelitsha Male 
Clinic (Cape Town), the Zola and Chiawelo 
clinics (both in Soweto) and the Yeoville clinic 
(central Johannesburg). These sites have built 
on the evidence and experience gained from 
providing services at the ITCMH. Guidelines 
for the management of common MSM health 
problems have been developed and packaged 
into an intensive training package, which 
can be delivered at healthcare facility level to 
improve staff attitudes and skills and better 
allow for the provision of non-judgemental, 
appropriate MSM-targeted healthcare. Over 
time, once enough state clinics have received 
such training, it is hoped that MSM-specific 
healthcare services can be mainstreamed 
in standard HIV/ART/STI clinics. Many 
resources have been developed locally and 
abroad to assist healthcare providers in caring 
for their MSM clients in a compassionate and 
competent manner, even in instances where 
the beliefs of healthcare workers do not usually 
encompass an understanding of diverse male 
sexual identities and behaviours.
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